Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
WuXi Biologics
Pharma
Boehringer-SBP, Fresenius-WuXi Bio, Evommune—Fierce Pharma Asia
BI formed a $7.4 billion tie-up with SBP. Fresenius collaborates with WuXi Bio in sweeping biosimilars deal. Evommune got a molecular glue from China.
Angus Liu
Nov 6, 2026 8:04am
Fresenius targets €370B originator market with WuXi Bio deal
Nov 2, 2026 9:43am
Viridian, awaiting FDA decision, taps WuXi Bio in supply deal
May 27, 2026 3:32pm
Takeda, GLP-1 generics, Gilead—Fierce Pharma Asia
Mar 27, 2026 8:38am
WuXi Bio's contracting business saw influx of US clients in '25
Mar 24, 2026 10:56am
Biosecure Act slips into key US defense bill
Dec 9, 2025 11:00am